Home » Topics » BioWorld Science

BioWorld Science
RSS

Dose-response trial of LAAM in opioid-dependent subjects

July 17, 1997

Promising preliminary results reported for Interneuron's ischemic stroke treatment

July 17, 1997

SIGA and Wyeth-Ayerst commence discovery program for novel antiinfectives

July 17, 1997

Possible mechanism of antiarthritic activity of TA-383 reported

July 17, 1997

Preliminary results reported for lisofylline in acute myeloid leukemia phase II trial

July 17, 1997

RS-67506 enhances lower intestinal propulsion in mice

July 17, 1997

New cardiovascular drugs reported by Yamanouchi

July 17, 1997

Nisshin Flour Milling describes new antiasthma drugs

July 17, 1997

FK-143: promising new BPH therapy

July 17, 1997

Fibrinogen-antagonistic oxopiperazine derivatives from Yamanouchi

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...